The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms
Open accessAbstract
Impairment of health after overcoming the acute phase of COVID-19 is being observed more and more frequently. Here different symptoms of neurological and/or cardiological origin have been reported. With symptoms, which are very similar to the ones reported but are not caused by SARS-CoV-2, the occurrence of functionally active autoantibodies (fAABs) targeting G-protein coupled receptors (GPCR-fAABs) has been discussed to be involved. We, therefore investigated, whether GPCR-fAABs are detectable in 31 patients suffering from different Long-COVID-19 symptoms after recovery from the acute phase of the disease. The spectrum of symptoms was mostly of neurological origin (29/31 patients), including post-COVID-19 fatigue, alopecia, attention deficit, tremor and others. Combined neurological and cardiovascular disorders were reported in 17 of the 31 patients. Two recovered COVID-19 patients were free of follow-up symptoms. All 31 former COVID-19 patients had between 2 and 7 different GPCR-fAABs that acted as receptor agonists. Some of those GPCR-fAABs activate their target receptors which cause a positive chronotropic effect in neonatal rat cardiomyocytes, the read-out in the test system for their detection (bioassay for GPCR-fAAB detection). Other GPCR-fAABs, in opposite, cause a negative chronotropic effect on those cells. The positive chronotropic GPCR-fAABs identified in the blood of Long-COVID patients targeted the β2-adrenoceptor (β2-fAAB), the α1-adrenoceptor (α1-fAAB), the angiotensin II AT1-receptor (AT1-fAAB), and the nociceptin—like opioid receptor (NOC-fAAB). The negative chronotropic GPCR-fAABs identified targeted the muscarinic M2-receptor (M2-fAAB), the MAS-receptor (MAS-fAAB), and the ETA-receptor (ETA-fAAB). It was analysed which of the extracellular receptor loops was targeted by the autoantibodies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Maideniuc, C., & Memon, A. B. (2020) · Journal of Neurology · doi:10.1007/s00415-020-10145-6 · Cited by 42
RetractedHarris, P. A., Taylor, R., Thielke, R., Payne, J., Gonzalez, N., & Conde, J. G. (2009) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2008.08.010 · Cited by 51,384
Persistent Symptoms in Patients After Acute COVID-19
Carfì, A., Bernabei, R., Landi, F., & for the Gemelli Against COVID-19 Post-Acute Care Study Group (2020) · JAMA · doi:10.1001/jama.2020.12603 · Cited by 4,561
Cardiovascular implications of fatal outcomes of patients with Coronavirus Disease 2019 (COVID-19)
Guo, T., Fan, Y., Chen, M., Wu, X., Zhang, L., He, T., Wang, H., Wan, J., Wang, X., & Lu, Z. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2020.1017 · Cited by 4,194
Autoantibodies against type I IFNs in patients with life-threatening COVID-19
Bastard, P., Rosen, L. B., Zhang, Q., Michailidis, E., Hoffmann, H.-H., Zhang, Y., Dorgham, K., Philippot, Q., Rosain, J., Béziat, V., et al. (2020) · Science · doi:10.1126/science.abd4585 · Cited by 2,662
Puntmann, V. O., Carerj, M. L., Wieters, I., Fahim, M., Arendt, C., Hoffmann, J., Shchendrygina, A., Escher, F., Vasa-Nicotera, M., Zeiher, A. M., et al. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2020.3557 · Cited by 2,208
Driggin, E., Madhavan, M. V., Bikdeli, B., Chuich, T., Laracy, J., Biondi-Zoccai, G., Brown, T. S., Der Nigoghossian, C., Zidar, D. A., Haythe, J., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.03.031 · Cited by 2,017
COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives
Nishiga, M., Wang, D. W., Han, Y., Lewis, D. B., & Wu, J. C. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-020-0413-9 · Cited by 1,409
Guillain–Barré Syndrome Associated with SARS-CoV-2
Toscano, G., Palmerini, F., Ravaglia, S., Ruiz, L., Invernizzi, P., Cuzzoni, M. G., Franciotta, D., Baldanti, F., Daturi, R., Postorino, P., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2009191 · Cited by 1,260
Diverse functional autoantibodies in patients with COVID-19
Wang, E. Y., Mao, T., Klein, J., Dai, Y., Huck, J. D., Jaycox, J. R., Liu, F., Zhou, T., Israelow, B., Wong, P., et al. (2021) · Nature · doi:10.1038/s41586-021-03631-y · Cited by 992
Angiotensin II Type 1–Receptor Activating Antibodies in Renal-Allograft Rejection
Dragun, D., Müller, D. N., Bräsen, J. H., Fritsche, L., Nieminen-Kelhä, M., Dechend, R., Kintscher, U., Rudolph, B., Hoebeke, J., Eckert, D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa035717 · Cited by 868
Self-citationAssociation of Cardiac Infection With SARS-CoV-2 in Confirmed COVID-19 Autopsy Cases
Lindner, D., Fitzek, A., Bräuninger, H., Aleshcheva, G., Edler, C., Meissner, K., Scherschel, K., Kirchhof, P., Escher, F., Schultheiss, H.-P., et al. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2020.3551 · Cited by 827
Ehrenfeld, M., Tincani, A., Andreoli, L., Cattalini, M., Greenbaum, A., Kanduc, D., Alijotas-Reig, J., Zinserling, V., Semenova, N., Amital, H., et al. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102597 · Cited by 559
Kreye, J., Reincke, S. M., Kornau, H.-C., Sánchez-Sendin, E., Corman, V. M., Liu, H., Yuan, M., Wu, N. C., Zhu, X., Lee, C.-C. D., et al. (2020) · Cell · doi:10.1016/j.cell.2020.09.049 · Cited by 347
Immunoglobulin Adsorption in Patients With Idiopathic Dilated Cardiomyopathy
Müller, J., Wallukat, G., Dandel, M., Bieda, H., Brandes, K., Spiegelsberger, S., Nissen, E., Kunze, R., & Hetzer, R. (2000) · Circulation · doi:10.1161/01.cir.101.4.385 · Cited by 340
Self-citationClinical and Autoimmune Characteristics of Severe and Critical Cases of COVID‐19
Zhou, Y., Han, T., Chen, J., Hou, C., Hua, L., He, S., Guo, Y., Zhang, S., Wang, Y., Yuan, J., et al. (2020) · Clinical and Translational Science · doi:10.1111/cts.12805 · Cited by 294
Loebel, M., Grabowski, P., Heidecke, H., Bauer, S., Hanitsch, L. G., Wittke, K., Meisel, C., Reinke, P., Volk, H.-D., Fluge, Ø., et al. (2016) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.09.013 · Cited by 244
Kohr, D., Singh, P., Tschernatsch, M., Kaps, M., Pouokam, E., Diener, M., Kummer, W., Birklein, F., Vincent, A., Goebel, A., et al. (2011) · Pain · doi:10.1016/j.pain.2011.06.012 · Cited by 192
Self-citationAutoantibodies against the angiotensin receptor (AT1) in patients with hypertension
Fu, M. L. X., Herlitz, H., Schulze, W., Wallukat, G., Micke, P., Eftekhari, P., Sjögren, K.-G., Hjalmarsona, Å., Müller-Esterl, W., & Hoebeke, J. (2000) · Journal of Hypertension · doi:10.1097/00004872-200018070-00017 · Cited by 179
Self-citationLyons-Weiler, J. (2020) · Journal of Translational Autoimmunity · doi:10.1016/j.jtauto.2020.100051 · Cited by 161
In-hospital cardiac arrest in critically ill patients with covid-19: multicenter cohort study
Hayek, S. S., Brenner, S. K., Azam, T. U., Shadid, H. R., Anderson, E., Berlin, H., Pan, M., Meloche, C., Feroz, R., O’Hayer, P., et al. (2020) · BMJ · doi:10.1136/bmj.m3513 · Cited by 154
Acute transverse myelitis after COVID-19 pneumonia
Munz, M., Weßendorf, S., Koretsis, G., Tewald, F., Baegi, R., Krämer, S., Geißler, M., & Reinhard, M. (2020) · Journal of Neurology · doi:10.1007/s00415-020-09934-w · Cited by 144
Wallukat, G., Morwinski, M., Kowal, K., Forster, A. J., Boewer, V., & WOLLENBERGER, A. (1991) · European Heart Journal · doi:10.1093/eurheartj/12.suppl_d.178 · Cited by 135
Self-citationAcute transverse myelitis in COVID-19 infection
Chow, C. C. N., MAGNUSSEN, J. S., Ip, J., & Su, Y. (2020) · BMJ Case Reports · doi:10.1136/bcr-2020-236720 · Cited by 114
Novelli, L., Motta, F., Santis, M. D., Ansari, A. A., Gershwin, M. E., & Selmi, C. F. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2020.102592 · Cited by 105
Dandel, M., Wallukat, G., Englert, A., Lehmkuhl, H. B., Knosalla, C., & Hetzer, R. (2012) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfs123 · Cited by 95
Self-citationShoenfeld, Y., Ryabkova, V. A., Scheibenbogen, C., Brinth, L. S., Martínez‐Lavín, M., Ikeda, S., Heidecke, H., Watad, ., Bragazzi, N. L., Chapman, J., et al. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108384 · Cited by 94
Rogue antibodies could be driving severe COVID-19
Khamsi, R. (2021) · Nature · doi:10.1038/d41586-021-00149-1 · Cited by 91 · cited 1×
“The possible impact of autoantibodies on the pathogenesis has most recently been discussed by Khamsi [27].”
Bradycardia in Patients With COVID-19: A Calm Before the Storm?
Amaratunga, E. A. D. T., Corwin, D. S., Moran, L. N., & Snyder, R. H. (2020) · Cureus · doi:10.7759/cureus.8599 · Cited by 91
Transverse Myelitis in a Child With COVID-19
Kaur, H., Mason, J. A., Bajracharya, M., McGee, J. C., Gunderson, M. D., Hart, B. L., Dehority, W. N., Link, N., Moore, B., Phillips, J., et al. (2020) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2020.07.017 · Cited by 75
COVID-19–associated acute transverse myelitis: a rare entity
Chakraborty, U., Chandra, A., Ray, A. K., & Biswas, P. (2020) · BMJ Case Reports · doi:10.1136/bcr-2020-238668 · Cited by 72
Lukitsch, I., Kehr, J., Chaykovska, L., Wallukat, G., Nieminen-Kelhä, M., Batuman, V., Dragun, D., & Gollasch, M. (2012) · Transplantation · doi:10.1097/tp.0b013e3182529bb7 · Cited by 69
Self-citationTransverse myelitis related to COVID-19 infection
Zachariadis, A., Tulbu, A., Strambo, D., Dumoulin, A., & Virgilio, G. D. (2020) · Journal of Neurology · doi:10.1007/s00415-020-09997-9 · Cited by 63
β 1 -Adrenoreceptor Autoantibodies in Heart Failure: Physiology and Therapeutic Implications
Düngen, H., Đorđević, A., Felix, S. B., Pieske, B. M., Voors, A. A., McMurray, J. J. V., & Butler, J. (2020) · Circulation Heart Failure · doi:10.1161/circheartfailure.119.006155 · Cited by 60
Kir, D., Mohan, C., & Sancassani, R. B. (2020) · JACC Case Reports · doi:10.1016/j.jaccas.2020.04.026 · Cited by 60
Kharraziha, I., Axelsson, J., Ricci, F., Di Martino, G., Persson, M., Sutton, R., Fedorowski, A., & Hamrefors, V. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.015989 · Cited by 54
Correcting the imbalanced protective RAS in COVID-19 with angiotensin AT2-receptor agonists
Steckelings, U. M., & Sumners, C. (2020) · Clinical Science · doi:10.1042/cs20200922 · Cited by 44
Functional autoantibodies in patients with different forms of dementia
Wallukat, G., Prüß, H., Müller, J., & Schimke, I. (2018) · PLoS ONE · doi:10.1371/journal.pone.0192778 · Cited by 35
Self-citationJünemann, A. G. M., Hohberger, B., Rech, J., Sheriff, A., Fu, Q., Schlötzer-Schrehardt, U. M., Voll, R. E., Bartel, S., Kalbacher, H., Hoebeke, J., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00145 · Cited by 35
Self-citationFouladseresht, H., Doroudchi, M., Rokhtabnak, N., Abdolrahimzadehfard, H., Roudgari, A., Sabetian, G., & Paydar, S. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.10.002 · Cited by 34
Cremer, S., Jakob, C. E. M., Berkowitsch, A., Borgmann, S., Pilgram, L., Tometten, L., Classen, A. Y., Wille, K., Weidlich, S., Gruener, B., et al. (2020) · Clinical Research in Cardiology · doi:10.1007/s00392-020-01769-9 · Cited by 30
Autoantibodies against G-protein-coupled receptors modulate heart mast cells.
Okruhlicová, Ľ., Morwinski, R., Schulze, W., Bartel, S., Weismann, P., Tribulová, N., & Wallukat, G. (2007) · PubMed · Cited by 26
Self-citationWenzel, K., Schulze-Rothe, S., Haberland, A., Müller, J., Wallukat, G., & Davideit, H. (2017) · Heliyon · doi:10.1016/j.heliyon.2017.e00362 · Cited by 15
Self-citationActivating autoantibodies against G protein-coupled receptors in narcolepsy type 1
Orjatsalo, M., Partinen, E., Wallukat, G., Alakuijala, A., & Partinen, M. (2020) · Sleep Medicine · doi:10.1016/j.sleep.2020.11.038 · Cited by 11
Self-citationAnalytics of Functional Autoantibodies in Patients with Chagas Disease
Wallukat, G., Wenzel, K., & Schimke, I. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9148-8_19 · Cited by 9
Self-citation
Cited by
Long COVID: major findings, mechanisms and recommendations
Davis, H. E., McCorkell, L., Vogel, J. M., & Topol, E. J. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00846-2 · Cited by 4,153
Distinguishing features of long COVID identified through immune profiling
Klein, J., Wood, J., Jaycox, J. R., Dhodapkar, R. M., Lu, P., Gehlhausen, J. R., Tabachnikova, A., Greene, K., Tabacof, L., Malik, A. A., et al. (2023) · Nature · doi:10.1038/s41586-023-06651-y · Cited by 806
The immunology and immunopathology of COVID-19
Merad, M., Blish, C. A., Sallusto, F., & Iwasaki, A. (2022) · Science · doi:10.1126/science.abm8108 · Cited by 751
Unexplained post-acute infection syndromes
Choutka, J., Jansari, V., Hornig, M., & Iwasaki, A. (2022) · Nature Medicine · doi:10.1038/s41591-022-01810-6 · Cited by 604
Pathophysiology and mechanism of long COVID: a comprehensive review
Castanares-Zapatero, D., Chalon, P., Kohn, L., Dauvrin, M., Detollenaere, J., Maertens de Noordhout, C., Primus-de Jong, C., Cleemput, I., & Van den Heede, K. (2022) · Annals of Medicine · doi:10.1080/07853890.2022.2076901 · Cited by 585
Metadata
- Authors
- Wallukat, G., Hohberger, B., Wenzel, K., Fürst, J., Schulze-Rothe, S., Wallukat, A., Hönicke, A.-S., & Müller, J.
- Venue
- Journal of Translational Autoimmunity
- Publisher
- Elsevier BV
- Published
- 2021
- Volume
- 4
- Pages
- 100100
- ISSN
- 2589-9090 (ISSN-L)
- OpenAlex
- W3155272051
- Cited by
- 362
- References
- 45
- FWCI
- 27.82
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.